Notice of rescheduled AGM

Paris, France and Camberley, UK – 29 September 2021 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that it will reschedule its Annual General Meeting (AGM) due to be held today at 2pm CEST/1pm BST to a later date. As usual, and in accordance with French corporate law, the

Visit Page

Half year 2021 results

Solid underlying financial performance and well-positioned for continued growthParis, France and Camberley, UK – 27 September 2021 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces its unaudited results for the half year ended 30 June 2021. http://novacyt.com/wp-content/uploads/2021/09/Novacyt-H1-results-final-.pdf

Visit Page

Proposed accounting treatment of ongoing DHSC dispute in 2021 interim results

Paris, France and Camberley, UK – 16 September 2021 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces the proposed accounting treatment of the ongoing DHSC dispute on its unaudited H1 2021 interim results for the six months ended 30 June 2021. The interim results are expected to be announced

Visit Page